The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency

Overview of attention for article published in Frontiers in immunology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 32,874 followers.

RT @FrontImmunol: New Research: The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selecte…

05 Jul 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selecte…

05 Jul 2021

Reply Repost Favourite

New Research: The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency: Background Patients with primary humoral immunodeficiency are more… https://t.co/12wv

05 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.